Birthday Girl Shruti Haasan Is Thankful To Her Lessons ‘(Pic Credit: Instagram/shrutzhaasan) Actress Shruti Haasan turned 35 on Thursday, and she says she wants her future to be filled with …
phase
-
- Gossips
Anil Kapoor opens up on ticking all boxes in his career’s new phase: More exciting things are being offered
In a recent interview, Anil Kapoor said that he finds himself in a ‘great situation’ with the kind of new age offers coming his way. Read on to know more. …
-
India’s first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the results published …
- News
Prime Minister Narendra Modi likely to receive COVID-19 vaccine in phase 2 of inoculation drive: Sources – India News , Firstpost
All chief ministers will also receive the vaccines in the next phase of the campaign, which may happen in March or April, according to media reports Prime Minister Narendra Modi. …
-
Prime Minister Narendra Modi will get the COVID-19 vaccine in the second phase of vaccination. Along with the PM, other leaders aged over 50 years will also be vaccinated. This …
- News
Himachal Pradesh panchayat polls: 80% voter turnout recorded in second phase – Politics News , Firstpost
In the first phase on Sunday, 1,227 panchayats had gone to polls, while voting will be held for 1,137 panchayats in the third and final phase on Thursday Representational Image. …
- Sports
AUS vs IND: Mohammed Siraj’s Brother Ismail Praises Virat Kohli, RCB For Backing Him During Tough Phase | Cricket News
Mohammad Ismail, brother of Indian fast bowler Mohammed Siraj on Tuesday said that the credit for Siraj’s performance needs to be given to Virat Kohli and Indian Premier League (IPL) …
-
Jewellery sales grew c15% y-o-y, sustaining the strong growth trend even after the festive season. Titan stock has rallied hard in a year of disruption, rising 36% in 2020, and …
-
With the world`s biggest vaccination drive slated to roll out across India from January 16, the Delhi government on Sunday said that it has made all preparations and finalised 89 …
-
Covaxin has been developed by Hyderabad-based Bharat Biotech. (File photo) Covaxin, indigenously developed by Bharat Biotech, has got approval for emergency use alongwith Oxford-AstraZeneca’s Covishield vaccine. PTI Raipur Last Updated: …
-
Ecuador’s ambassador to India Hector Cueva Jacome has expressed his confidence in Indian COVID vaccines, highlighting that are ‘part of the solution’. He himself was part of phase-3 trials of …
- News
Shashi Tharoor critcises Centre for giving nod to Bharat Biotech vaccine without phase 3 trials
Congress leader Shashi Tharoor has criticised the government for giving the nod to Bharat Biotech’s COVID-19 vaccine without phase-3 trials. The central licensing authority has granted permission to Bharat Biotech …
-
India has enough stockpile of the COVID-19 vaccine for inoculation of priority groups, including healthcare workers and frontline workers, in the first phase, Niti Aayog member V K Paul said …
- News
Enough stockpile of COVID-19 vaccine for inoculation of priority groups in first phase: V.K. Paul
Niti Aayog member V.K. Paul noted that “three to four months from now, there will be other vaccines and the stockpile will be even bigger”. India has enough stockpile of …
-
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country’s first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of …
- News
Coronavirus News LIVE Updates: Bharat Biotech recruits 26,000 volunteers for Phase 3 COVAXIN trials which began November 2020 – India News , Firstpost
Coronavirus News LIVE Updates: The company’s chairman Dr Krishna Ella called DGCI’s approval for COVAXIN ‘a giant leap for innovation and novel product development in India’ Coronavirus News LATEST Updates: Expressing …
-
Harsh Vardhan added that details of how the remaining 27 crore priority beneficiaries will be vaccinated by July are being finalised Health Minister Harsh Vardhan on Saturday said that free …
-
KABUL, Afghanistan — After four decades of grinding combat in Afghanistan, peace negotiations between the Afghan government and the Taliban have raised at least a possibility that the long cycle …
-
The polling for second and final phase of Gram Panchayat elections in Karnataka concluded on Sunday and the counting of votes will be taken up on December 30. According to …
- News
COVID-19 vaccine: Delhi govt to inoculate 51 lakh people in phase one, says Arvind Kejriwal – India News , Firstpost
The first priority group includes 3 lakh health workers, 6 lakh frontline workers, and a group of 42 lakh people who are older than 50 years and people below 50 …
-
National flags of the U.S. and China fly outside a company building in the China (Shanghai) Pilot Free Trade Zone in Shanghai, China on Oct. 22, 2013. Tomohiro Ohsumi | …
- Bollywood
Abhishek Bachchan: Enjoying this phase of my life where people are offering me varied roles
Written by Arushi Jain | New Delhi | December 23, 2020 7:00:25 am Abhishek Bachchan made his digital debut in 2020. In 2020, Abhishek Bachchan made a successful foray into …
-
Srinagar: The authorities in Jammu and Kashmir heaved a sigh of relief rather are happy over the eight-phased polling for the Union Territory’s first-ever District Development Council (DDC) elections passing …
-
Srinagar: Twenty-eight constituencies will go to polls in the eighth and final phase of District Development Council (DDC) elections on Saturday. Addressing a press conference on Friday, State Election Commissioner …
- News
Covaxin produces ‘robust’ antibody response with no serious adverse events, Phase 1 trials show – Health News , Firstpost
The findings have appeared on medRxiv, a preprint server. A preprint is a version of a scientific manuscript posted on a public server prior to formal peer review COVAXIN vaccine …
- News
Bharat Biotech’s phase 1 trial findings show COVID-19 vaccine well tolerated; no serious adverse events
The interim findings of phase 1 clinical trial of COVID-19 vaccine Covaxin, indigenously developed by Bharat Biotech in collaboration with the ICMR, showed that it was was well tolerated in …